Discovery and mechanism of action of novel hEag1 potassium channel lead molecules with anti-cancer activity
01. January 2019 - 31. December 2022 | 1.00 Natural sciences and mathematics
Cancer remains an important cause of mortality and economic losses worldwide. The Bilateral Project provides excellent research in new anticancer discovery for the treatment of gastrointestinal (GI) carcinomas (colorectal, gastric, liver and pancreatic cancers), where hEag1 potassium channels are overexpressed in 75 to 100% cases. GI carcinomas are among the 10 most...